Noven Pharmaceuticals, a specialty pharmaceutical company, has appointed Peter Amanatides as its new vice president of quality assurance & quality control, effective immediately. In this role, Mr Amanatides will lead all aspects of Noven's quality functions.
Subscribe to our email newsletter
Prior to Noven, Mr Amanatides served DSM Pharmaceuticals in several senior quality roles. Most recently, Mr Amanatides has served as senior director of quality operations and regulatory affairs, the senior-most quality officer at DSM Pharmaceuticals.
Mr Amanatides holds a master of science degree in biotechnology and molecular biology from Hood College and a bachelor of science degree in biology from Regents College.
Peter Brandt, president and CEO of Noven, said: “Peter will play an important role in our plan to establish Noven as a high growth specialty pharmaceutical company with uncompromised quality systems, controls and procedures. He has substantial experience and a record of accomplishment in the industry, and will lead our continuing efforts to enhance quality operations across the organization.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.